Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 3 5Phase NA 4Phase 4 3Phase 2/3 1Phase 1/2 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Vomiting 6Neoplasms 4Nausea 3Lymphoma 1Leukemia 1Breast Neoplasms 1

Interventions

Dexamethasone 5Aprepitant 5Palonosetron 3Ondansetron 3Granisetron 3Calcium Dobesilate 3Metoclopramide 2naldemedine 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1alizapride 1Tropisetron 1Tablets 1Duration of Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Nausea × Palonosetron × Clear all
NCT00684463 2017-05-16

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Merck Sharp & Dohme LLC

Phase 4 Completed
59 enrolled

Nausea, Neoplasms, Vomiting

NCT00687011 2017-05-15

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

Merck Sharp & Dohme LLC

Phase 4 Completed
118 enrolled

Nausea, Neoplasms, Vomiting

NCT00415103 2009-09-18

AMENO-2

PETHEMA Foundation

Phase 4 Completed
196 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡